go to The University of Arizona website
Home

Brian Erstad, PharmD

Professor

Department Head

Department(s):
Pharmacy Practice & Science
Primary Phone: 520-694-5600
Secondary Phone: 520-626-4289
Location: Drachman Hall Room B211D

Brian L. Erstad, PharmD, FCCM, is currently a tenured professor and head of the Department of Pharmacy Practice and Science. He is also a center investigator for the Center for Health Outcomes and PharmacoEconomics Research and a co-director for the Arizona Clinical and Translational Research Graduate Certificate Program. His clinical responsibilities are performed at University of Arizona Medical Center-University Campus, where he is program director for the postgraduate year two (PGY2) critical care pharmacy residency. 

Dr. Erstad’s research interests pertain to critical care medicine with an emphasis on patient safety and related outcomes research. He has authored more than 150 peer-reviewed articles and book chapters. 

Dr. Erstad has served on the board of directors of the American Society of Health-System Pharmacists and on numerous committees and task forces for other organizations including AHRQ, USP, Society of Critical Care Medicine and the American College of Chest Physicians. He is currently a member of the FDA’s Drug Safety and Risk Management Advisory Committee and a steering committee member of the United States Critical Illness and Injury Trials (USCIIT) Group. 

Dr. Erstad was the first pharmacist to receive the Society of Critical Care Medicine’s Shubin-Weil Master Clinician/Teacher Excellence Award.

 

 

Education

BS, South Dakota State University, 1976

PharmD, University of Arizona, 1987

Publications

Monographs/National Guidelines

1. Erstad BL. Technology Report: Serum Albumin (author of monograph). UHC Technology Advancement Center, September 1992; 1-56.

2. Vermeulen LC, et al. Technology Assessment: Albumin, Nonprotein Colloid, and Crystalloid Solutions (exercise participant and contributing reviewer) UHC Technology Advancement Center, December, 1993 (Revised 5/00).

3. Yim JM et al. Technology Report: Results of the UHC Albumin and Nonprotein Colloid Solutions Multicenter Technology Use Surveillance (exercise participant and contributing reviewer) UHC Technology Advancement Center, November 1994.

4. Erstad BL, Grant K. ASHP Therapeutic Guidelines on stress ulcer prophylaxis (Project Coordinator). Am J Health-Syst Pharm 1999;56:347-79.

5. Murray MJ, Cowen J, DeBlock H, Erstad BL, Gray AW, Tescher AN, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002;30:142-156 (also published in the Am J Health-Syst Pharm).

6. Rubinson L, Hick JL, Curtis JR, Branson RD, Burns S, Christian MD, Devereaux AV, Dichter JR, Talmor D, Erstad B, Medina J, Geiling JA. Definitive care for the critically ill during a disaster: medical resources for surge capacity. CHEST 2008;133:32S-50S (also member of Steering Committee associated with all related papers in supplement).

Chapters in Scholarly Books and Handbooks

1. Erstad BL. Medication Dosing in Overweight and Obese Patients. In: Murphy JE, ed. Clinical Pharmacokinetics, 4th edition. Bethesda, MD: American Society of Health-System Pharmacists, 2008;19-26.

2. Erstad BL. Hypovolemic Shock. In: DiPiro et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 7th edition. Stamford, CT: Appleton & Lange 2008;441-453.

3. Erstad BL. Hypovolemic Shock. In: Schwinghammer TL, Koehler J, eds. Pharmacotherapy Casebook: A Patient-Focused Approach (and Instructor's Guide).7th ed. New York: McGraw-Hill, 2008:22:1-4.

4. Erstad BL. Antimicrobial Prophylaxis in Surgical Patients. In, Mushlin SB, Greene HL, eds. Decision Making in Medicine: An Algorithmic Approach. 3rd edition. Mosby Elsevier, Philadelphia, PA 2010:700-701.

5. Erstad BL. Use and Monitoring of Aminoglycoside Antibiotics. In, Mushlin SB, Greene HL, eds. Decision Making in Medicine: An Algorithmic Approach. 3rd edition. Mosby Elsevier, Philadelphia, PA 2010:704-707.

6. Rominski JM, Matthias KR, Erstad BL. Use and Evaluation of Serum Drug Levels. In, Mushlin SB, Greene HL, eds. Decision Making in Medicine: An Algorithmic Approach. 3rd edition. Mosby Elsevier, Philadelphia, PA 2010:708-711.

7. Erstad BL. Surviving and Thriving in the Academic Setting. In: Zlatic TD, ed. Clinical Faculty Survival Guide. American College of Clinical Pharmacy, Lenexa, KS 2010:21-36.

8. Adriance SM, Erstad BL. Intra-Abdominal Infection. In: Katz MD, Matthias KR, Chisholm-Burns MA, eds. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach. McGraw-Hill Companies, Inc., New York, NY 2011:331-334.

9. Stahle SA, Erstad BL. Sepsis Syndromes. In: Katz MD, Matthias KR, Chisholm-Burns MA, eds. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach. McGraw-Hill Companies, Inc., New York, NY 2011:355-358.

10. Erstad BL. Hypovolemic Shock. In: DiPiro et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 8th edition. Stamford, CT: Appleton & Lange 2011;421-435.

11. Erstad BL. Hypovolemic Shock. In: Schwinghammer TL, Koehler J, eds. Pharmacotherapy Casebook: A Patient-Focused Approach.8th ed. New York: McGraw-Hill, 2011;91-92.

12. Erstad BL, Patanwala AE. Teaching and Precepting: Assuming the Role of an Educator. In: Murphy JE, ed. Resident Survival Guide. AmericanCollege of Clinical Pharmacy, Lenexa, KS 2011:53-68.

13. Erstad BL. Medication Dosing in Overweight and Obese Patients. In: Murphy JE, ed. Clinical Pharmacokinetics. 5th ed. American Society of Health-System Pharmacists, Bethesda, MD 2012:19-28.

14. Erstad BL. Special Caveats of Drugs Used in Critical Care Medicine. In: Roberts PR, Todd SR, eds. Comprehensive Critical Care: Adult. Society of Critical Care Medicine, Mount Prospect, IL 2012;779-789.

15. Erstad BL. Drug Dosing in the Critically Ill Obese Patient. In: El Solh AA, ed. Critical Care Management of the Obese Patient. John Wiley & Sons, Ltd, Hoboken, NJ 2012:197-207.

16. Patanwala AE, Erstad BL. Reporting Patient Safety Events. In: Papadopoulos J, et al., eds. Drug-Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment. Society of Critical Care Medicine, Mount Prospect, IL 2012:449-456.

17. Erstad BL, Hoyland M. Step VII: Maximize Experiential Education. In: Bauman JI, Sims KA, eds. The ACCP Field Guide to Becoming a Standout Pharmacy Residency Candidate. American College of Clinical Pharmacy, Lenexa, KS 2012:89-112.

18. Erstad BL. Postgraduate Year Two (PGY2) Pharmacy Residency Training Programs. In: Crouch MA, ed. Securing and Excelling in a Pharmacy Residency. Jones & Bartlett Learning, Burlington, MA 2013:49-56.

19. Adriance SM, Erstad BL. Intra-Abdominal Infection. In: Katz MD, Matthias KR, Chisholm-Burns MA, eds. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach. McGraw-Hill Companies, Inc., New York, NY 2014:353-356.

20. Stahle SA, Erstad BL. Sepsis. In: Katz MD, Matthias KR, Chisholm-Burns MA, eds. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach. 3rd edition. McGraw-Hill Companies, Inc., New York, NY 2014:377-380.

21. Erstad BL. Hypovolemic Shock. In: Schwinghammer TL, Koehler J, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 9th ed. New York: McGraw-Hill, 2014:93-95.

              Refereed Journal Articles- Original Research (past 5 years)

1. Nolan PE Jr., Marcus FI, Erstad BL, et al. Effects of coadministration of propafenone on the pharmacokinetics of digoxin in healthy volunteer subjects.  J Clin Pharmacol 1989;29:46-52.

2. Nolan PE, Erstad BL, Hoyer GL, Bliss M, Gear K, Marcus FI. Steady-state interaction between amiodarone and phenytoin in normal subjects. Am J Cardiol 1990;65:1252-7.

3. Gales BJ and Erstad BL. Albumin audit results and guidelines for use. J Pharm Technol 1992;8:125-9.

4. Erstad BL, Snyder BA, Kramer T. Epidural, intrathecal, and patient-controlled analgesic use in a university medical center. J Pharm Technol 1993;9:141-3.

5. Erstad BL, Harlander DK, Daller JA. Hematologic effects of alcohol consumption in trauma patients. Ann Pharmacother 1993;27:889-91.

6. Erstad BL, Ortmeier BG, Hubbard JH, Judkins DG. Native American trauma at a university medical center. The Provider (Indian Health Service/Public Health Service) 1994;19:9-12.

7. Erstad BL, Campbell DJ, Rollins CJ, Rappaport WD. Albumin and prealbumin concentrations in patients receiving postoperative parenteral nutrition. Pharmacotherapy 1994;14:458-62.

8. Erstad BL, Draugalis JR, Waldrop SM, et al. Patients' perceptions of increased pharmacy contact. Pharmacotherapy 1994:14:724-8.

9. Erstad BL, Murphy JE. Developing critical interaction skills in students: debating clinical pharmacokinetic controversies. Am J Pharm Educ 1994;58:440-5.

10. Whipple JK, Quebbeman EJ, Esser MJ, Lewis KS, Gottlieb MS, McKindley DS, Hess M, Boucher BA, Jancik JT, Wesley LC, Erstad BL, Ausman RK. Current patterns of prescribing and administering morphine in trauma patients. Pharmacotherapy 1995;15:210-5.

11. Vermeulen LC, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA. A paradigm for consensus: The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 1995;155:373-9.

12. Carl JL, Erstad BL, Murphy JE, Slack MK. Infusion syringe device comparison study for medication delivery. Am J Hosp Pharm 1995;52:1428-32.

13. O'Connell H, Erstad BL. Comparison of predicted and measured energy expenditure in mechanically ventilated obese patients. J Pharm Technol 1995;11:47-9.

14. Kinkade RE, Mathews CT, Draugalis JR, Erstad BL. Evaluation of a computer simulation in a therapeutics case discussion. Am J Pharm Educ 1995;59:147-50.

15. Yim JM, Vermeulen LC, Erstad BL, Matuszewski KA, Burnett DA, Vlasses PH. Albumin and nonprotein colloid solution use in U.S. academic health centers Arch Intern Med 1995;155:2450-5.

16. Erstad BL, Grier DG, Scott ME, Esser MJ, Joshi P. Recognition and treatment of ethanol abuse in trauma patients. HEART & LUNG: The Journal of Critical Care 1996;25(4):330-6.

17. Erstad BL, Chopda S, Esser MJ. Prescribing of analgesics in trauma patients. Amer J Ther 1997;4:27-30.

18. Erstad BL, Meeks ML, Chow HH, Rappaport WD, Levinson ML. Intramuscular meperidine administration in elderly postoperative patients. Ann Pharmacother 1997;31:23-8.

19. Erstad BL, McIntyre K. Prospective, randomized comparison of ampicillin-sulbactam and cefoxitin for diabetic foot infections. Vasc Surg 1997;31:419-25.

20. Erstad BL, Callahan P, Keller J.  Evaluation of practice site learning experience for entry-level Doctor of Pharmacy students. Am J Pharm Educ 1997;61:87-90.

21. Erstad BL, Camamo JM, Miller MJ, Anthony M. Webber, Fortune J. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center. Crit Care Med 1997;25:1678-84.

22.  Erstad BL, Costa CM, Daller JA, Fortune JB. Lack of hematologic effects or recent ethanol ingestion. Am J Ther 1999;6:299-302.

23. Erstad BL, Tong T. Evaluation of learning skills development and computer-assisted learning strategies with an orientation program. Am J Pharm Educ 1999;63:182-5.

24. Erstad BL, Richards H, Rose S, Nakazato P, Fortune J. Influence of twenty-five per cent human serum albumin on total and ionized calcium concentrations in vivo. Crit Care 1999;3:117-21.

25. Erstad BL. Pharmacoeconomic comparison of an albumin-furosemide complex versus sequential therapy for renal insufficiency. Clin Ther 1999;21:1380-6.

26. Erstad BL, Barletta JF, Jacobi J, et al. Survey of stress ulcer prophylaxis. Crit Care 1999;3:145-9.

27. Erstad BL, Favre JK. Written testing of students in the experiential setting.  Amer J Pharm Educ 2000;63:426-9.

28. BarlettaJF, Erstad BL, Loew M, Keim SM. A prospective study of pain control in the emergency department.  Am J Ther 20007:251-6.

29. Barletta JF, Johnson SB, Nix DE, Nix LC, Erstad BL. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. J Trauma 2000;49:869-72.

30. Armstrong EP, Patrick KL, Erstad BL. Comparison of preoperative skin preparation products. Pharmacotherapy 2001;21:345-50.

31. Calabrese AD, Erstad BL, Brandl K, Barletta JF, Kane SL, Sherman DS. Medication administration errors in adult patients in the ICU. Intensive Care Med 2001;27:1592-8.

32. Keim SM, Erstad BL, Sakles JC, Davis V. Etomidate for procedural sedation in the emergency department. Pharmacotherapy 2002;22:586-92.

33. Bolesta S, Erstad BL. The use of metoclopramide in ileus: A look at duration of therapy. Hosp Pharm 2002;37:949-52.

34. Barletta JF, Erstad BL. Stress ulcer prophylaxis in trauma patients. Crit Care 2002;6:526-30.

35. Thomas MC, Erstad BL. Safety of enteral naloxone and IV neostigmine when used to relieve constipation. Am J Health-Syst Pharm 2003;60:1264-7.

36.  Herout PM, Erstad BL. Medication errors involving continuously infused medications in a surgical intensive care unit. Crit Care Med 2004;32:428-32.

37. Allen ME, Kopp BJ, Erstad BL. Stress ulcer prophylaxis in the postoperative period. Am J Health-Syst Pharm 2004;61:588-96.

38. Erstad BL. Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer related bleeding. Crit Care Med 2004;32:1277-83.

39. Adams RJ, Armstrong EP, Erstad BL. Prescribing and self-administration of morphine in Hispanic and non-Hispanic Caucasian patients treated with patient-controlled analgesia. J Pain Palliat Care Pharmacother 2004;18:29-38.

40. Camamo JM, McCoy RH, Erstad BL. Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome. Pharmacotherapy 2005;25:184-90.

41. Olson LM, Desai S, Soto ML, Namazifard S, Quelland A, Erstad BL. Evaluation of pharmacists’ interventions at a university teaching hospital.  Can J Hosp Pharm 2005;58:20-5.

42. Kopp, BJ, Erstad, BL, Allen, ME, Theodorou AA, Priestley G. Medication errors and adverse drug events in an intensive care unit: Direct observation approach for detection. Crit Care Med 2006;34:415-25.

43. Nix DF, Erstad BL, Nakazato PZ, et al. Estimation of creatinine clearance in end-stage liver disease. Ann Pharmacother 2006;40:900-8.

44. Erstad AJ, Erstad BL, Nix DE. Accuracy and reproducibility of small-volume injections from various-sized syringes. Am J Health-Syst Pharm 2006;63:748-50.

45. Patanwala A, Abarca J, Huckleberry Y, Erstad BL. Pharmacologic management of constipation in the critically ill patient. Pharmacotherapy 2006;26:896-902.

46. Pantanwala AE, Erstad BL, Nix DE. Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections. Curr Med Res Opin 2007;23:185-93.

47. Buckley MS, Erstad BL, Kopp BJ, Theodorou AA, Priestley G. Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit. Pediatr Crit Care Med 2007;8:145-52.

48. Erstad BL, Schultz JM. Prophylactic antibiotic compliance with published guidelines. J Pharm Pract 2007;19.5:300-5.

49. Koopman E, Nix DE, Erstad BL, Demeure MJ, Hayes MM, Ruth JT, Matthias KR. End-of-procedure cefazolin concentrations after administration for prevention of surgical-site infection. Am J Health-Syst Pharm 2007;64:1927-34.

50. Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of actual and potential adverse events prevented by interventions of a critical care pharmacist.  Am J Health-Syst Pharm 2007;64:2483-7.

51. Duby JJ, Erstad BL, Abarca J, Camamo JM, Huckleberry Y, Bramblett SN.  Impact of delayed initiation of erythropoietin in critically ill patients. BMC Blood Disord 2007;7:1.doi: 10.1186/1471-2326-7-1

52. Patanwala AE, Jarzyna DL, Miller MD, Erstad BL. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty. Pharmacotherapy 2008;28:1453-60.

53. Patanwala AE, Norris CJ, Nix DE, Kopp BJ, Erstad BL. Vancomycin dosing for pneumonia in critically ill trauma patients. J Trauma Inj Infect Crit Care 2009;67:802-4.

54. Fernandez J, Erstad BL, Petty W, Nix DE. Time to positive culture and identification for Candida bloodstream infections. Diag Micro Infect Dis 2009;64:402-7..

55. Patanwala AE, Warholak TL, Sanders AB, Erstad BL. A prospective observational study of medication errors in a tertiary care emergency department. Ann Emerg Med 2010;55:522-6.

56. Hennings S, Romero A, Erstad BL, Franke H, Theodorou AA. A comparison of automated infusion device technology to prevent medication errors in pediatric and adult intensive care unit patients. Hosp Pharm 2010;45:464-71.

57. Jacques KA, Erstad BL. Availability of information for dosing injectable medications in underweight or obese patients. Am J Heatlh-Syst Pharm 2010;67:1948-50.

58. Patanwala AE, Stahle SA, Sackles JC, Erstad BL. Comparison of succinylcholine and rocuronium for first-attempt intubation success in the emergency department. Acad Emerg Med 2011;18:11-14.

59. Patanwala AE, Biggs AD, Erstad BL. Patient weight as a predictor of pain response to morphine in the emergency department. J Pharm Pract 2011;24:109-113.

60. Patanwala AE, Hays DP, Sanders AB, Erstad BL.  Severity and probability of harm of medication errors intercepted by an emergency department pharmacist. Int J of Pharm Pract 2011;19:358-62.

61. Baggs JH, Patanwala AE, Williams EM, Erstad BL. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal. Ann Pharmacother 2012;46:51-56.

62. Patanwala AE, Sanders AB, Thomas MC, Acquisto NM, Weant KA, Baker SM, Merritt E, Erstad BL. A prospective, multicenter study of pharmacist activities resulting in medication error interception in the emergency department. Ann Emerg Med 2012;59:369-73.

63. Doungngern T, Huckleberry Y, Bloom JW, Erstad BL. Effect of albumin on diuretic response to furosemide in patients with hypoalbuminemia. Am J Crit Care 2012;21:280-6.

64. Jasiak KD, Middleton EA, Camamo JM, Erstad BL, Snyder LS, Huckleberry YC. Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium. J Pharm Pract published online November 26, 2012: DOI: 10.1177/0897190012465987.

65. Patanwala AE, Holmes KH, Erstad BL. Analgesic response to morphine in obese and morbidly obese patients in the emergency department. Emerg Med J published online January 12, 2013: doi:10.1136/emermed-2012-202168.

66. Amini A, Faucett EA, Watt JM, Amini R, Sakles JC, Rhee P, Erstad BL, Patanwala AE. Effect of a pharmacist on timing of postintubation sedative and analgesic use in trauma resuscitations. Am J Health-Syst Pharm 2013;70:1513-7.

67. Traylor BR, Patanwala AE, Sackles JC, Erstad BL. Under-doing of etomidate for rapid sequence intubation in the emergency department. Curr Drug Saf 2013;8:253-6.

68. Radosevich JJ, Patanwala A, Erstad BL. Hepatotoxicity in Obese versus Non-Obese Patients with Acetaminophen Poisoning who are treated with Intravenous N-acetylcysteine. Am J Ther 2013 doi: 10.1097/01.mjt.0000434043.62372.00.

69. Radosevich JJ, Nix D, Erstad BL. Evaluation of the treatment of candiduria at an academic medical center. Am J Ther 2013 doi: 10.1097/01.mjt.0000434043.62372.00.

70. Patanwala AE, Mckinney C, Erstad BL, Sakles JC. Retrospective analysis of etomidate versus ketamine for first pass intubation success in an academic emergency department. Acad Emerg Med 2014;21:88-91.

71. Shearin AE, Patanwala AE, Tang A, Erstad BL. Predictors of hypotension associated with propofol in trauma patients. J Trauma Nurs 2014;21:4-8.

72. Aljuhani OA, McKinney CB, Erstad BL. Opioid requirements in mechanically ventilated patients receiving dexmedetomidine versus propofol. J Trauma Nurs 2014;21:111-114.

              Refereed Journal Articles- Nonexperimental(literature reviews, case reports with literature review)

73. Erstad BL.  Prevention of Amphotericin B Toxicity.  Clin Trends Hosp Pharm 1987;1:31-5.

74. Katz M, Erstad B, Rose K.  Treatment of severe cryptosporidium-related diarrhea with octreotide in a patient with AIDS.  Drug Intell Clin Pharm 1988;22:134-5.

75. Erstad BL.  Sucralfate in the prophylaxis and treatment of stress-induced bleeding.  J Pharm Technol 1988;4:138-43.

76. Katz MD, Erstad BL.  Octreotide:  review of a new somatostatin analogue.  Clin Pharm 1989;8:255-73.

77. Erstad BL.  Severe cardiovascular adverse effects in association with acute, high-dose corticosteroid administration.  Drug Intell Clin Pharm 1989;23:1019-23.

78. Erstad BL, Gales BJ, Rappaport WD.  The use of albumin in clinical practice.  Arch Int Med 1991;151:901-11. (Also requested to abbreviate English version of article for international translation/readership). Erstad BL. Utilización de la albúmina en la práctica clínica. Pharmacy Digest 1991;3:10-12.

79. Daller JA, Erstad BL, Rosado L, Otto C, Putnam CW. Aminophylline antagonizes the neuromuscular blockade of pancuronium but not vecuronium. Crit Care Med 1991;19:983-5.

80. Erstad BL, Witte CL, Talkington DK. Toxic shock-like syndrome. Pharmacotherapy 1992;12:23-27.

81. Erstad BL. Massive gastrointestinal bleeding associated with ketorolac administration. J Pharm Practice 1992;5:11-12.

82. Erstad BL. Dapsone-induced methemoglobinemia and hemolytic anemia. Clin Pharm  1992;11:800-5 [selected as Grand Rounds article by Editor].

83. Erstad BL. Serum albumin levels: who needs them? Ann Pharmacother 1992;26:1134-8 [article also converted to Spanish edition (Concentraciones de seroalbumina: quien las necesita?) since it was one of "the best" articles "that appeared in our English-language edition."]

84. Gales BJ, Erstad BL. Adverse reactions to human serum albumin. Ann Pharmacother 1993;27:87-94.

85. Erstad BL. How to be an effective clerkship or internship preceptor. Am J Hosp Pharm 1993;50:434-9.

86. Erstad BL, Meeks ML. Influence of injection site and route on medication absorption. Hosp Pharmacy 1993;28:853-78.

87. Erstad BL. Fluid replacement therapy. Pharm Times 1994;60:62-73 (accredited C.E. article).

88. Erstad BL, Lipsy RJ. Adverse gastrointestinal effects of nonsteroidal anti-inflammatory drugs. J Pharm Practice 1994;7:144-58.

89. Erstad BL, Rappaport WD. Subcapsular hematoma following laparoscopic cholecystectomy associated with ketorolac administration. Pharmacotherapy 1994;14:613-5.

90. Erstad BL. A rational approach to the management of acute pain states (part 1). Hosp Formul 1994;29:516-25 (accredited C.E. article).

91. Erstad BL. A rational approach to the management of acute pain states (part 2). Hosp Formul 1994;29:586-593 (accredited C.E. article).

92. Erstad BL. Fluid replacement therapy. J Pract Nurs 1994;9:24-33 (revision of fluid resuscitation article for nurses).

93. Erstad BL. Oxygen transport goals in the resuscitation of critically ill patients. Ann Pharmacother 1994;28:1273-84 (accredited C.E. article).

94. Erstad BL, Cotugno CL. Management of alcohol withdrawal. Am J Hosp Pharm 1995;52:697-709.

95. Erstad BL. An introduction to acute pain assessment and management. Am J Pharm Educ 1995;59:180-4.

96. Newsom L, Erstad BL, Nakazato PZ, Daller JA. Falsely elevated total calcium concentration in serum associated with iron dextran injection. Pharmacotherapy 1995;15:789-92.

97. Erstad BL. Viral infectivity of albumin and plasma protein fraction. Pharmacotherapy 1996;16:996-1001.

98. Erstad BL. Using residency standards to prepare staff pharmacists for patient care activities. Am J Health-Syst Pharm 1996;53:2696-9.

99. Maloney M, Camamo J, Crinnion C, Johnson S, Erstad BL. Development of intensive care unit algorithms. Am J Health-Syst Pharm 1997;54:1841-5.

100. Erstad BL. Venous thromboembolism in multiple trauma patients. Pharmacotherapy 1998;18:1011-1023.

101. Erstad BL. General therapeutic considerations in patients with acute renal failure. Am J Pharm Educ 1999;63:209-213.

102.  Erstad BL. Concerns with defining appropriate uses of albumin by meta-analysis. Am J Health-Syst Pharm 1999;56:1451-4.

103. Erstad BL, Armstrong DK. The application of animal models to critical care patients. Crit Care Med 1999;27:2045-6.

104. Erstad BL. Overseas Report: Application of the ECHO model to clinical practice. Curr Conc Hosp Pharm (Japanese) 1999;15:6-8.

105. Erstad BL, Barletta JF. Treatment of hypertension in the perioperative patient.  Ann Pharmacother 2000;34:66-79.

106. Erstad BL.  Enteral nutrition support in acute pancreatitis. Ann Pharmacother 2000;36:514-21.

107. Erstad BL. ICU sedation. Hosp Pharm 2000;35:675-6.

108. Erstad BL. Octreotide for acute variceal bleeding. Ann Pharmacother 2001;35:618-26(accredited C.E. article).

109. Erstad BL. Proton-pump inhibitors for acute peptic ulcer bleeding. Ann Pharmacother 2001;35:730-40(accredited C.E. article).

110. Erstad BL. Systemic hemostatic medications for reducing surgical blood loss. Ann Pharmacother 2001;35:925-34(accredited C.E. article).

111. Erstad BL. Antifibrinolytic agents and desmopressin as hemostatic agents in cardiac surgery. Ann Pharmacother 2001;35:1075-84(accredited C.E. article).

112. Erstad BL. Implications of prion-induced diseases for animal-derived pharmaceutical products. Am J Health-Syst Pharm 2002;59:254-60.

113. Erstad BL. Laboratory monitoring: Back to basics. Am J Pharm Educ 2002;56:199-3.

114. Erstad BL. Dyspepsia: initial evaluation and treatment. J Am Pharm Assoc 2002;42:460-8.

115. Erstad BL. Which weight for weight-based dosing regimens in obese patients? Am J Health-Syst Pharm2002;59:2105-10.

116. Erstad BL. Jordan CJ. Thomas MC. Key articles and guidelines relative to intensive care unit pharmacology.  Pharmacotherapy 2002;22:1594-1610.

117. Huckleberry Y, Thomas MC, Erstad BL. Dosing conversions as a potential cause of adverse drug events. Am J Health-Syst Pharm 2003;60:189-91.

118. Erstad BL. Dosing of medications in morbidly obese patients in the intensive care unit setting. Intensive Care Med  2004;30:18-32.

119. Pajoumand M, Erstad BL, Camamo JM. Use of epoetin alfa in critically ill patients. Ann Pharmacother 2004;38:641-8.

120. Erstad BL. What is the evidence for using hemostatic agents in surgery? Eur Spine J 2004;13:S28-S33.

121. Erstad BL, Martin SJ, Brophy GM, Haas CE, Jacobi J, Welage LS, Thomas MC. Key articles and guidelines relative to intensive care unit pharmacology-2004. Pharmacotherapy 2005;25:585-610.

122. Slikker W, Young JF, Corley RA, Dorman DC, Conolly RB, Knudsen TB, Erstad BL, Luecke RH, Faustman EM, Timchalk C, Mattison DR. Improving predictive modeling in pediatric drug development: Pharmacokinetics, pharmacodynamics, and mechanistic modeling. Ann NY Acad  Sci 2005;1053:1-14.

123. Patanwala A, Duby J, Waters D, Erstad BL. Opioid conversions in acute care. Ann Pharmacother 2007;41:255-67.

124. Erstad BL. A primer on critical care pharmacy services. Ann Pharmacother 2008;42:1871-81.

125. Erstad BL, Puntillo K, Gilbert HC, et al. Pain management principles in the critically ill. CHEST2009;135:1075-86.

126. Puntillo K, Pasero C, Li D, Mularski RA, Grap MJ, Erstad BL, Varkey B, Gilbert HC, Medina J, Sessler CN. Evaluation of pain in ICU patients. CHEST 2009;135:1069-74.

127. Mularski RA, Puntillo K, Varkey B, Erstad BL, Grap MJ, Gilbert HC, Li D, Medina J, Sessler CN. Pain management within the palliative and end-of-life care experience in the ICU.CHEST 2009;135:1360-9.

128. Pasero C, Puntillo K, Li D, Mularski RA, Grap MJ, Erstad BL, Varkey B, Gilbert HC, Medina J, Sessler CN. Structured approaches to pain management in the ICU. CHEST 2009;135:1665-72.

129. Erstad BL, Brophy GM, Martin SJ, Haas CE, Devlin JW, Welage LS, Dager W. Key articles and guidelines relative to intensive care unit pharmacotherapy: 2009 update. Pharmacotherapy 2009;29:1228-69.

130. Lat I, Foster DR, Erstad BL. Drug-induced acute liver failure and gastrointestinal complications. Crit Care Med 2010;38(suppl):S175-87.

131. Patanwala AE, Amini A, Erstad BL. Hypertonic saline use in trauma patients. Am J Heatlh-Syst Pharm 2010;67:1920-8.

132. Patanwala AE, Keim, SM, Erstad BL. Intravenous opioids for severe acute pain in the emergency department. Ann Pharmacother 2010;44:1800-9.

133. Erstad BL, Haas CE, O’Keeffe T, et al. Interdisciplinary patient care in the ICU setting: focus on the pharmacist. Pharmacotherapy 2011;31:128-37.

134. Patanwala AE, Acquisto NM, Erstad BL. Prothrombin complex concentrate for critical bleeding. Ann Pharmacother 2011;45:990-9.

135. Patanwala AE, Barletta JF, Erstad BL. Pharmacoepidemiology and patient safety in the critically ill. Pharmaceuticals Policy Law 2012;14:93-104.

136.  Johnson SG, Kayser SR, Attridge RL, Duvall L, Kiser TH, Moote R, Reed BN, Rodgers JE, Erstad B. Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update. Pharmacotherapy 2012;32:e134–69.

137. Erstad BL. Patanwala AE, Theodorou AA. Comparison of methods for the detection of medication safety events in the critically ill. Curr Drug Saf 2012;7:238-46.

138. Radosevich JJ, AE Patanwala, Erstad BL. Emerging pharmacological agents to improve survival from traumatic brain injury. Brain Inj 2013;27:1492-1499.

              Letters and Editorials

139. Erstad BL. Osmolality and osmolarity: Narrowing the terminology gap. Pharmacotherapy 2003;23:1085-6.

140. Erstad BL. Developing models for pharmacy practice. Am J Health-Syst Pharm 2010;67(letter):23-24.

141. Erstad BL. Colloids and renal dysfunction: Another brick in the wall of safety concerns. Crit Care Med 2011;39:1565-6.

142. Erstad BL. Colloids and renal dysfunction: Another brick in the wall of safety concerns. Crit Care Med 2011;39(editorial):1565-6.

143. Nix DE, Matthias KR, Erstad BL. Vancomycin clearance in overweight and obese patients. Am J Health-Syst Pharm 2011;68(letter):1776-7.

144. Erstad BL. Obesity in critical illness: What weight or why weight? Crit Care Med 2012;40(editorial):1657-60.

145. MacLean LG, Brazeau GA, Chestnut RJ, Erstad BL, Gant KO, Pitman EP, et al. Report of the 2012-2013 Professional Affairs Committee: Tables of Influence—Is Pharmacy Hungry Enough? Am J Pharm Educ 2013;77(10):Article S21.

146. Erstad BL. Stress ulcer prophylaxis: It’s that same old wine in a brand new bottle. Crit Care Med 2014;42:979-80.

147. Engle JP, Erstad BL, Anderson DC, et al. Minimum qualifications for clinical pharmacy practice faculty. Pharmacotherapy 2014;34:e38-44.

Scholarly Presentations (past 5 years)                                                               

Submitted With Abstracts

              International

1. Erstad BL, Barletta JF, Fortune J. “Stress Ulcer Prophylaxis in Trauma Patients,” presented at the International Congress on Clinical Pharmacy, Orlando, Florida; April 1999.

2. Kopp BK, Allen M, Erstad BL, et al. “System Analysis of Adverse Drug Events Using a Continuous Observation Approach in an ICU,” presented at the 2nd American College of Clinical Pharmacy/European Society of Clinical Pharmacy International Congress on Clinical Pharmacy, Paris, France; April 2004.

3. Patanwala A, Erstad BL, Jarzyna D, Miller M. “Post-operative pain management in opioid naïve and opioid tolerant patients after orthopedic surgery,” International Conference on Clinical Pharmacy, Istanbul, Turkey; October 2007.

4. Kopp BK, Erstad BL, Schultz JM. “Impact of prolonged morphine infusions in ICU patients with or without renal insufficiency,” American College of Clinical Pharmacy/European Society of Clinical Pharmacy International Congress on Clinical Pharmacy, Orlando, Florida; April 2009.

5. McKinney CB, Patanwala AE, Sakles JC, Erstad BL. “Effect of etomidate versus ketamine on intubation success in the emergency department,” presented at the Society of Critical Care Medicine’s Annual Meeting, San Juan, Puerto Rico; January 2013.

National

1. Kopp BJ, Theodorou AA, Buckley MS, Erstad BL, Priestley G. An Evaluation of Medication Errors and Adverse Drug Events (ADEs) in a Pediatric ICU,” presented at Society of Critical Care Medicine’s 35th Educational and Scientific Symposium, San Francisco, CA; January 2006.

2. Duby JJ, Erstad BL, Abarca J, et al. Epoetin Alfa in the Critically Ill Patient: Published Trials Versus Practice,” presented at American Society of Health-System Pharmacists Summer Meeting, Orlando, FL; June 2006.

3. Patanwala A, Erstad BL, Nix DE. “Cost-Effectiveness of Linezolid Versus Vancomycin in the Treatment of Surgical Site Infections,” presented at the American College of Clinical Pharmacy Annual Meeting, St. Louis, MO Oct 2006.

4. Dang KH, Huckleberry Y, Abarca J, Smoyer R, Erstad B. “Glycemic Control in Ward Patients After Tight Control with Insulin Infusions in the Intensive Care Unit,” presented at American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim, CA; Dec 2006.

5. Schultz JM, Erstad BL. “Evaluation of Surgical Antibiotic Prophylaxis in an Academic Medical Center,” presented at American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim, CA; Dec 2006.

6.  Patanwala A, Norris CJ, Nix DE, Erstad BL. “Vancomycin Dosing for Pneumonia in Critically Ill Patients,” presented at the Society of Critical Care Medicine’s 36th Educational and Scientific Symposium, Honolulu, Hawaii; February 2008.

7. Fernandez J, Nix D, Erstad B, Petty W. “Time Between Blood Culture Collection and Positive Results Reported for Candida species,” presented at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ; April 2008.

8. Erstad BL, Patanwala A. “Integration of Didactic and Experiential Education to Smooth Transition to the Acute Care Setting,” presented at the American Association of Colleges of Pharmacy Annual Meeting, Chicago, IL; July 2008.

9. Biggs A, Patanwala A, Erstad B, Chase P. “Factors Affecting Morphine Dosage in Treating Severe Pain in the Emergency Department,” presented at the American College of Clinical Pharmacy Annual Meeting, Louisville, KY; Oct 2008.

10. Patanwala A, Warholak Terri, Sanders A, Erstad BL. “A Prospective Observational Study of Medication Errors in a Tertiary Care Academic Emergency Department ,” presented at the American College of Emergency Physician’s ACEP Research Forum, Boston, Mass; Oct 2009.

11. Stahle S, Patanwala A, Hays D, Sakles J, Erstad BL. “Effect Of Sedative and Paralytic Dosing on First Attempt Success Rates During Rapid Sequence Intubation in the Emergency Department,” presented at the American College of Clinical Pharmacy Annual Meeting, Anaheim, CA; Oct 2009.

12. Hennings S, Romero A, Erstad BL, Franke H, Theodorou AA. “Use of Automated Infusion Device Technology in Critically Ill Patients to Avoid Adverse Drug Events Associated with High-Risk Medications.” presented at the Society of Critical Care Medicine’s 39th Educational and Scientific Symposium, Miami, Fl; January 2010.

13. Baggs JH, Patanwala AE, Williams E, Erstad BL. “Adequacy of International Normalized Ratio (INR) Reversal After Receiving 3-Factor Prothrombin Complex Concentrate,” presented at the American College of Clinical Pharmacy Annual Meeting, Austin, TX; Oct 2010.

14. Jacques KA, Erstad BL. “Availability of Information for Dosing Injectable Medications in Underweight and Obese Patients,” presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim, CA; Dec 2010.

15. Stahle S, Adriance S, Kopp B, Erstad B. “Effectiveness of Levetiracetam Versus Phenytoin for Early Seizure Prophylaxis Following Traumatic Brain Injury,” presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim, CA; Dec 2010.

16. Doungngern T, Huckleberry Y, Erstad B, Bloom J. “Furosemide Versus Furosemide/Albumin Combination on Urine Output in Hypoalbuminemic Critically Ill Patients,” presented at the American Society of Health-System Pharmacists Summer Meeting, Denver, CO; June 2011.

17. Patanwala AE, Sanders AB, Thomas MC, Acquisto NM, Weant KA, Baker SM, Merritt E, Erstad BL. A prospective, multicenter study of medication errors intercepted by emergency department pharmacists.  American College of Emergency Physicians, San Francisco, CA; Oct 2011.

18. Holmes K, Patanwala A, Erstad B. Effect of body mass index on analgesic response to morphine. presented at the Society of Critical Care Medicine’s 41th Educational and Scientific Symposium, Houston, TX; February 2012.

19. Traylor BR, Patanwala AE, Sackles JC, Erstad BL. Etomidate dosing variability based on weight for rapid sequence intubation in the emergency department. presented at the Society of Critical Care Medicine’s 41th Educational and Scientific Symposium, Houston, TX; February 2012.

20. Shearin AE, Patanwala AE, Tang A, Erstad BL. “Hypotension associated with propofol in the emergency department,” presented at the American College of Clinical Pharmacy Annual Meeting, Hollywood, FL; October 2012.

21. Radosevich J, Nix DE, Erstad BL. “Evaluation of the treatment of candiduria in intensive care unit and non-intensive care units patients at an academic medical center,” presented at the American College of Clinical Pharmacy Annual Meeting, Hollywood, FL; October 2012.

22. Patanwala AE, Mckinney C, Erstad BL, Sakles JC. “Effect of Etomidate versus Ketamine on Intubation Success in the Emergency Room,” presented at the Society of Critical Care Medicine’s Educational and Scientific Symposium, San Juan, Puerto Rico; January 2013.

23. Gowler A. Erstad B, Tang A. “Comparison of Low-Molecular-Weight Heparin and Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Trauma Patients,” presented at the American College of Clinical Pharmacy Virtual Poster Symposium; May 2013.

24. Radosevich J, Patanwala A, Erstad B. “Norepinephrine Dosing in Obese Patients for the Management of Septic Shock,” presented at the American College of Clinical Pharmacy Virtual Poster Symposium; May 2013.

25. Radosevich JJ, Patanwala A, Erstad BL. “Efficacy and Safety of Intravenous N-acetylcysteine in Obese versus Non-obese Patients with Acetaminophen Toxicity,”presented at the American College of Clinical Pharmacy Annual Meeting; October 2013.

26. Aljuhani OA, McKinney CB, Erstad BL. “Opioid Requirements in Mechanically Ventilated Trauma Patients Receiving Dexmedetomidine versus Propofol,” presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, Fl; December 2013.

27. Barletta J, Kanji S, MacLaren R, Lat I, Erstad B. “Current Trends in the Use of Stress Ulcer Prophylaxis- a Multicenter Study,” presented at the Society of Critical Care Medicine’s Educational and Scientific Symposium, San Francisco, CA; January 2014.

28. Erstad B, Camamo J, Weibel K, O’Keeffe TO. “Cost Savings with Interventions to Reduce Aerosolized Bronchodilator Use in Ventilated Patients,” presented at the Society of Critical Care Medicine’s Educational and Scientific Symposium, San Francisco, CA; January 2014.

29. Patanwala A, Erstad B. “Comparison of Dexmedetomidine Versus Propofol for Patients in the Intensive Care Unit,” presented at the Society of Critical Care Medicine’s Educational and Scientific Symposium, San Francisco, CA; January 2014.

30. Abraham P, Barletta J, Bauer S, Brophy G, Erstad B, Flynn J et al. “The Development and Description of a Pharmacotherapy Research Network,” presented at the Society of Critical Care Medicine’s Educational and Scientific Symposium, San Francisco, CA; January 2014.

31. Miller L, Weibel K, Erstad B. “"Medication Reconciliation during Transition of Care: From Hospital Discharge to First Refill,” presented at the ACCP 2014 Virtual Poster Symposium (runner-up in Best Poster Competition); May 2014.

INVITED PRESENTATIONS

              International

1.  “Is Sugar Nice in the ICU,”American College of Clinical Pharmacy/European Society of Clinical Pharmacy International Congress on Clinical Pharmacy, Orlando, FL, April 2009.

2. “Dosing Medications in the Morbidly Obese: Is More Better,” presented at the Society of Critical Care Medicine’s Annual Meeting, San Juan, Puerto Rico; January 2013.

3. “Mentoring Residents: Preceptor Pearls,” presented at the Optimizing Pharmacy Education and Training meeting, Riyadh, Saudi Arabia; February 2013.

4. “Critical Care Practice: Methods of medication error and adverse drug event detection,” presented at the First International Conference on Medication Safety, Al-Ahsa, Saudi Arabia; March 2014.

5. “Critical Care Practice: The impact of the pharmacist and technologies on patient safety,” presented at the First International Conference on Medication Safety, Al-Ahsa, Saudi Arabia; March 2014.

National

1. “Pharmacology of the morbidly obese patient,” presented at Society of Critical Care Medicine’s 35th Educational and Scientific Symposium, San Francisco, CA; January 2006.

2. “Traditional Pharmacological Management of ICU Pain,” ICU Pain Consensus Meeting, American College of Chest Physicians, Tucson, AZ; March 2006.

3. “An Evidence-Based Approach to Clinical Decision Making in the ICU,” American Society of Health-System Pharmacists Summer Meeting, Orlando, FL; June 2006

4. “Use of Pharmacoeconomics in the ICU,” Excellence in Quality and Safety in Critical Care conference, Baltimore, MD; September 2006.

5. “The Increasing Role of the Pharmacist in the Management of Postoperative Ileus,” moderator and speaker for symposium in conjunction with American College of Clinical Pharmacy Annual Meeting, St. Louis; Oct 2006.

6. “Pharmacological Agents for Managing Sedation and Analgesia,” American College of Chest Physicians annual meeting, Salt Lake City, Utah; October 2006.

7. “Bicarbonate in Paris,” presented at American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim, CA; Dec 2006.

8. “ABGs and Acid-Base Status,” presented at the American Society of Parenteral and Enteral Nutrition (ASPEN) annual meeting, Phoenix, AZ; Sept 2007.

9. “Key Lessons for Being an Excellent Educator,” American College of Clinical Pharmacy annual meeting, Denver, CO; October 2007.

10. “Interdisciplinary Management of Sedation and Analgesia in the ICU: Pharmacologic Management Issues,” American College of Chest Physicians annual meeting, Chicago, IL; October 2007.

11. “Developing a Quality Medication-Use Evaluation Program,” group facilitator at American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas; Dec 2007.

12. “Not All Islands are the Same: Pharmacotherapy in Morbidly Obese Patients,” presented at the Society of Critical Care Medicine’s 36th Educational and Scientific Symposium, Honolulu, Hawaii; February 2008.

13. “Medication Errors and Adverse Drug Reactions in the ICU,” presented at the Society of Critical Care Medicine’s 36th Educational and Scientific Symposium, Honolulu, Hawaii; February 2008.

14. "Effects of Morbid Obesity on Dosing,” presented at the Society of Critical Care Medicine’s 36th Educational and Scientific Symposium, Honolulu, Hawaii; February 2008.

15. “Interpreting ABG’s and Acid-Base Status,” presented at the American Society of Parenteral and Enteral Nutrition (ASPEN) annual meeting, Chicago, Ill; February 2008.

16. “Clinical Pearls for Residency,” roundtable discussion at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ; April 2008.

17. “How to Better Detect and Prevent Adverse Events and Medication Errors in Your ICU,” moderator and speaker at the American Society of Health-System Pharmacists Summer Meeting, Seattle, WA; June 2008.

18. “Incorporating Scholarship into Clinical Practice,” Section of Teachers of Pharmacy Practice, American Association of Colleges of Pharmacy Annual Meeting, Chicago, IL; July 2008.

19. “I’m a New Practitioner Now,” Great Expectations Conference for New Practitioners, American Society of Health-System Pharmacists, New York, NY; August 2008.

20. “Integrating Specialized Tips into Your Daily Practice,” Great Expectations Conference for New Practitioners, American Society of Health-System Pharmacists, New York, NY; August 2008.

21. “Involvement in National Organizations: A Win-Win Opportunity,” Great Expectations Conference for New Practitioners, American Society of Health-System Pharmacists, New York, NY; August 2008.

22. “Being an Effective Preceptor,” presented at the American College of Clinical Pharmacy Annual Meeting, Louisville, KY Oct 2008.

23. “Managing Pain in the ICU: Pharmacologic Management,” American College of Chest Physicians annual meeting, Philadelphia, PA; October 2008.

24. “Developing a Rigorous Medication-Use Evaluation Program – Applying the Principles of Descriptive Research,” group facilitator at American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL; Dec 2008.

25. “Pharmacokinetic Dosing Dilemmas in Current Clinical Practice – Dosing in Obesity,” American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL; Dec 2008.

26. “Applying Analytical Research Principles in Medication Use Evaluation,” group facilitator at American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL; Dec 2008.

27. “Bedside Teaching,” Society of Critical Care Medicine’s 38th Critical Care Congress, Nashville, TN; Jan/Feb 2009.

28. “High-Risk Medications in the ICU,” Society of Critical Care Medicine’s 38th Critical Care Congress, Nashville, TN; Jan/Feb 2009.

29. “Interpreting Acid-Base Status with Blood Gases,” presented at the American Society of Parenteral and Enteral Nutrition (ASPEN) annual meeting, New Orleans, LA; February 2009.

30. “Medication Dose Adjustments for Obese Patients,” presented at the American Pharmacists Association Annual Meeting, San Antonio, Tx, April 2009.

31. “Procedural Sedation in the Emergency Department,” presented at the American College of Clinical Pharmacy Annual Meeting, Anaheim, CA; Oct 2009.

32. “Who Wants to be a Millionaire? The Short and Sweet of Scientific Writing,” presented at the 44th ASHP Midyear Clinical Meeting; Las Vegas, NV; Dec 2009.

33. “Who You Buggin? ID Pearls,” presented at the 44th ASHP Midyear Clinical Meeting; Las Vegas, NV; Dec 2009.

34. “Developing a Rigorous Medication-Use Evaluation Program – Applying the Principles of Descriptive Research,” group facilitator at the 44th ASHP Midyear Clinical Meeting; Las Vegas, NV; Dec 2009.

35. “Optimizing Patient Comfort with Safe and Effective Sedation,” presented at the 44th ASHP Midyear Clinical Meeting; Las Vegas, NV; Dec 2009.

36. “A Review of the Fluids and Factors Used for Resuscitation,” moderator and session presenter at the 44th ASHP Midyear Clinical Meeting; Las Vegas, NV; Dec 2009.

37. “Is Sugar Nice in the ICU,” clinical pearl presented at the 44th ASHP Midyear Clinical Meeting; Las Vegas, NV; Dec 2009.

38. “Heparin and Low Molecular Weight Heparin Dosing in Difficult Situations,” presented at the 44th ASHP Midyear Clinical Meeting; Las Vegas, NV; Dec 2009.

39. “The Graying of Albumin,” presented (and session moderator) at the Society of Critical Care Medicine’s 39th Educational and Scientific Symposium, Miami, Fl; January 2010.

40. “The Weight is Over: Now What,” presented (and session moderator) at the Society of Critical Care Medicine’s 39th Educational and Scientific Symposium, Miami, Fl; January 2010.

41. “Interpreting Arterial Blood Gases and Acid-Base Status” and “The Basic Metabolic Panel,” Postgraduate Course presented at the American Society of Parenteral and Enteral Nutrition (ASPEN) annual meeting, Las Vegas, NV; February 2010.

42.  “Taking a Scholarly Approach to Your Practice,” speaker and facilitator for Clinical Career Advancement symposium, American College of Clinical Pharmacy Annual Meeting, Austin, TX; Oct 2010.

43. “Using Portfolios to Guide and Document Your Continuous Professional Development,” facilitator for Clinical Career Advancement symposium, American College of Clinical Pharmacy Annual Meeting, Austin, TX; Oct 2010.

44. “Inadequate Analgesia for the Opioid Tolerant Patient in the ED to the ICU Setting,” presented at the American College of Clinical Pharmacy Annual Meeting, Austin, TX; Oct 2010.

45. “Guidelines: When and Where Do They Apply,” presented at the ASHP Midyear Clinical Meeting; Anaheim, CA; Dec 2010.

46. “Pain Management in the Intensive Care Unit and Case Discussion,” presented at the ASHP Midyear Clinical Meeting, Anaheim, CA; Dec 2010.

47. “General Principles of Drug Dosing in Obesity,” presenter and Program Chair for session at the ASHP Midyear Clinical Meeting, Anaheim, CA; Dec 2010.

48. “Residency Accreditation,” presented at the Society of Critical Care Medicine’s Pre-Congress Symposium, San Diego, CA; January 2011.

49. “Line Infections: When to Treat or Pull,” presented at the Society of Critical Care Medicine’s  40th Annual Critical Care Congress, San Diego, CA; January 2011.

50. “Supportive Care: Analgesia and Beyond,” presenter and Program Chair for session at the ASHP Summer Meeting, Denver, CO; June 2011.

51. “The Renal Panel: Beyond the Normal Range,” presenter and Program Chair for session at the ASHP Summer Meeting, Denver, CO; June 2011.

52. “Taking a Scholarly Approach to Your Practice,” speaker and facilitator for Clinical Career Advancement symposium, American College of Clinical Pharmacy Annual Meeting, Pittsburgh, PA; Oct 2011.

53. “Using Portfolios to Guide and Document Your Continuous Professional Development,” facilitator for Clinical Career Advancement symposium, American College of Clinical Pharmacy Annual Meeting, Pittsburgh, PA; Oct 2011.

54. “Fluid Resuscitation and Bleeding Cessation,” presented at the ASHP Midyear Clinical Meeting, New Orleans, LA; December 2011.

55. “Determining Appropriate Drug Dosing in Obesity and Other Special Populations,” presented at the ASHP Midyear Clinical Meeting, New Orleans, LA; December 2011.

56. “Medication Errors and Adverse Drug Events in the ICU,” presented and moderated at the ASHP Midyear Clinical Meeting, New Orleans, LA; December 2011.

57. “Management of Pain in the Intensive Care Unit,” presented at the ASHP Midyear Clinical Meeting, New Orleans, LA; December 2011.

58. “Neuromuscular Blockade for all ARDS Patients?,” presented at the Society of Critical Care Medicine’s 41th Educational and Scientific Symposium, Houston, TX; February 2012.

59. “Clinical Interpretation of Common Laboratory Parameters,” presented at the Vital Care Home Infusion Services Annual Meeting, New Orleans, LA; March 2012.

60. “General Principles of Drug Dosing in Obesity,” presented at the ASHP Summer Meeting, Baltimore, MD; June 2012.

61. “Medication Dosing in Obese and Overweight Patients,” presented at the The Obesity Society’s 30th Annual Scientific Meeting, San Antonio, Tx; September 2012.

62. “Pain, Agitation, Delirium Guideline,” moderator and panelist at the Society of Critical Care Medicine’s Pharmacotherapy in Critical Illness meeting (co-chair for entire meeting), New Orleans, LA; October 2012.

63. “Fluid Resuscitation: New Drugs and Technologies,” presented at the American College of Clinical Pharmacy Annual Meeting, Hollywood, Fl; October 2012.

64. “Taking a Scholarly Approach to Your Practice,” speaker and facilitator for Clinical Career Advancement symposium, American College of Clinical Pharmacy Annual Meeting, Pittsburgh, PA; Oct 2012.

65. “Using Portfolios to Guide and Document Your Continuous Professional Development,” facilitator for Clinical Career Advancement symposium, American College of Clinical Pharmacy Annual Meeting, Pittsburgh, PA; Oct 2012.

66. “So You Wanna Be a Preceptor: Old Dog New Tricks,” presented at the ASHP Midyear Clinical Meeting, Las Vegas; December 2012.

67. “Precepting PGY-2 Pharmacy Residents: Above and Beyond PGY-1 Precepting,” presented at the ASHP Midyear Clinical Meeting, Las Vegas; December 2012.

68. “Residency Precepting: Strategies Worth Sharing,” presented at the ASHP Midyear Clinical Meeting, Las Vegas; December 2012.

69. “Pain Management in the ICU,” presented at the ASHP Midyear Clinical Meeting, Las Vegas; December 2012.

70. “Dosing Medications in the Morbidly Obese: Is More Better,” presented at the Society of Critical Care Medicine’s Educational and Scientific Symposium, San Juan, Puerto Rico; January 2013.

71. “Application of New Sedation/Analgesia Guidelines,” presented at the ASHP Summer Meeting, Minneapolis, MN; June 2013.

72. “Effectively Orienting Residents to Your Program,” presented at the ASHP Summer Meeting, Minneapolis, MN; June 2013.

73. “Medication Dosing in Obese and Overweight Patients,” presented at the ASHP Summer Meeting, Minneapolis, MN; June 2013.

74. “Using Portfolios to Guide and Document Your Continuous Professional Development,” facilitator for Clinical Career Advancement symposium, American College of Clinical Pharmacy Annual Meeting, Albuquerque, NM; Oct 2013.

75. “The Old Perspective: It is NOT a Reality,” presented at the ASHP Midyear Clinical Meeting, Orlando, FL; December 2013.

76. “Honey I Shrunk the Evidence,” presented at the ASHP Midyear Clinical Meeting, Orlando, FL; December 2013.

77. “Transition from ICU to Ward,” presented at the ASHP Midyear Clinical Meeting, Orlando, FL; December 2013.

78. “What You Need to Know about Guidelines,” presented at the ASHP Midyear Clinical Meeting, Orlando, FL; December 2013.

79. “Long Term Mentoring: From Mentoring to Collaboration,” presented at the Pre-Congress Pharmacy Symposium, Society of Critical Care Medicine’s Educational and Scientific Symposium, San Francisco, CA; January 2014.

Updated: Monday, 04 August 2014